Nexstim (Finland) a commercial-stage developer of non-invasive brain imaging technologies focused on cortical mapping prior to surgery, closed a $2.8M Series D financing, bringing the total round to $19.2M. Participants include Capricorn Health-tech Fund, Tekes, HealthCap, Sitra, Finnish Industry Investment, Lundbeckfond Ventures and Ilmarinen.

Neuronetics (Malvern, PA) a commercial-stage medical device company focused on pulsed magnetic field stimulation for non-invasive, non-systemic treatment of depression, closed a $30M Series E financing. Participants include Polaris Venture Partners, Pfizer Venture Investments, Investor Growth Capital, New Leaf Venture Partners, Interwest Partners, Three Arch Partners, Quaker BioVentures and Onset Ventures.

EmSense (San Francisco, CA) a commercial-stage device company focused on cognitive neuroscience, analytics, and market research through a wireless, scalable, non?invasive EEG neuroscience technology, closed a $9M Series C financing. Participants include Technology Partners and Foundry Group.

Note: 2009 Year-in-Review Trend Analysis Coming 15 Feb

Orasi Medical (Edina, MN) an early-stage medical device company focused on the development of a technology to diagnose and monitor neurological disorders using electrical brain activity, closed a $3.5M Series B financing. Participants include CentreStone Ventures and PrairieGold Venture Partners.

Autonomic Technologies (Menlo Park, CA) n early-stage medical device company focused on implantable neurostimulators, closed a $20M Series B financing. Participants include InterWest Partners and others.

PhotoThera (Carlsbad, CA) a clinical-stage medical device company focused on transcranial laser therapy (TLT) for the treatment of acute ischemic stroke and other neurological diseases , closed a $50M Series D financing. Participants include Warburg Pincus, Vertical Group, Hamilton BioVentures, Delphi Ventures, DeNovo Ventures and others.

Nexstim (Finland) a commercial-stage developer of non-invasive brain imaging technologies focused on cortical mapping prior to surgery, closed a $7.9M Series C financing. Participants include Tekes, HealthCap, Life Sciences Partners, Sitra and Finnish Industry Investment Ltd.

MindFrame (Lake Forrest, CA) developer of devices for ischemic stroke treatment, closed a $6M Series A financing. Participants include SV Life Sciences and Intersect Partners.

Autonomic Technologies (Menlo Park, CA) makers of neuromdoulation stimulation devices closed on the first $3M traunche of a $5M Series A financing. Participants in the round include Kleiner Perkins Caufield & Byers and the Cleveland Clinic.